Context Therapeutics Inc banner

Context Therapeutics Inc
F:6K9

Watchlist Manager
Context Therapeutics Inc Logo
Context Therapeutics Inc
F:6K9
Watchlist
Price: 1.92 EUR -4%
Market Cap: €144m

Wall St Price Targets

6K9 Price Targets Summary
Context Therapeutics Inc

Wall Street analysts forecast 6K9 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6K9 is 2.89 EUR with a low forecast of 1.91 EUR and a high forecast of 4.46 EUR.

Lowest Forecast
Price Target
1.91 EUR
1% Downside
Average Forecast
Price Target
2.89 EUR
51% Upside
Highest Forecast
Price Target
4.46 EUR
132% Upside
Context Therapeutics Inc Competitors:
Price Targets
CPNREIT
CPN Retail Growth Leasehold REIT
0% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-82%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6K9's stock price target?
Price Target
2.89 EUR

According to Wall Street analysts, the average 1-year price target for 6K9 is 2.89 EUR with a low forecast of 1.91 EUR and a high forecast of 4.46 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett